Continuous subcutaneous insulin infusion
Showing 1 - 25 of >10,000
Type2diabetes Trial in Nanning (Henagliflozin, Continuous Subcutaneous Insulin Infusion)
Not yet recruiting
- Type2diabetes
- Henagliflozin
- Continuous Subcutaneous Insulin Infusion
-
Nanning, Guangxi, ChinaFirst Affiliated Hospital of Guangxi Medical University
Jan 9, 2023
Diabetes, Type 1, Type 1 Diabetes Trial in Escondido (coil-reinforced soft polymer indwelling cannula, soft Teflon indwelling
Completed
- Diabetes Mellitus, Type 1
- Type 1 Diabetes
- coil-reinforced soft polymer indwelling cannula
- soft Teflon indwelling catheter
-
Escondido, CaliforniaAMCR Institute
Aug 9, 2022
Type 1 Diabetes Trial in Little Rock, Denver, West Des Moines (Insulin aspart SAR341402, Insulin aspart)
Completed
- Type 1 Diabetes Mellitus
- Insulin aspart SAR341402
- Insulin aspart
-
Little Rock, Arkansas
- +2 more
Apr 21, 2022
Diabetes, Covid19 Trial in Naples (Continuous glucose monitoring (CGM, Dexcom G6))
Terminated
- Diabetes Mellitus
- Covid19
- Continuous glucose monitoring (CGM, Dexcom G6)
-
Naples, ItalyFederico II University Hospital
Jul 26, 2022
Type 2 Diabetes, Pregnancy in Diabetic Trial in Beijing (Continuous subcutaneous insulin infusion (CSII), Multiple daily insulin
Not yet recruiting
- Type 2 Diabetes
- Pregnancy in Diabetic
- Continuous subcutaneous insulin infusion (CSII)
- Multiple daily insulin injection (MDI)
-
Beijing, Beijing, ChinaPeking University Third Hospital
Nov 28, 2021
Real-world Data for In-silico Evaluation ofNew Software
Completed
- Diabetes Mellitus, Type 1
- YpsoPump® insulin pump system
-
Ulm, Germany
- +1 more
Mar 21, 2022
Type 1 Diabetes Trial in New Haven (canagliflozin, basal interruption without canagliflozin)
Completed
- Type 1 Diabetes
- canagliflozin
- basal interruption without canagliflozin
-
New Haven, ConnecticutYale University School of Medicine
Sep 17, 2021
Type 1 Diabetes Trial in Loma Linda, Austin (Afrezza (insulin human) Inhalation Powder, insulin degludec, Continuous
Recruiting
- Type 1 Diabetes
- Afrezza (insulin human) Inhalation Powder
- +2 more
-
Loma Linda, California
- +1 more
Apr 12, 2022
Diabetes, Type 1 Trial in Graz (NNC0471-0119 A, NNC0471-0119 B, NNC0471-0119 D)
Active, not recruiting
- Diabetes Mellitus, Type 1
- NNC0471-0119 A
- +3 more
-
Graz, AustriaNovo Nordisk Investigational Site
Aug 15, 2022
Type 1 Diabetes, Dermatologic Complication Trial in Herlev (Skin Care Program)
Active, not recruiting
- Type 1 Diabetes
- Dermatologic Complication
- Skin Care Program
-
Herlev, DenmarkDepartment of Pediatrics, Herlev Hospital
Feb 11, 2022
Type 1 Diabetes With Hypoglycemia Trial in Caen, Montpellier (Closed-loop insulin infusion driven by continuous glucose
Recruiting
- Type 1 Diabetes Mellitus With Hypoglycemia
- Closed-loop insulin infusion driven by continuous glucose monitoring through an algorithm, in free-life conditions
- Continuous Subcutaneous Insulin Infusion and Continuous Glucose Monitoring
-
Caen, France
- +1 more
Dec 14, 2021
Diabetes, Type 1 Trial in Mainz (LY900014, Insulin Lispro)
Completed
- Diabetes Mellitus, Type 1
- LY900014
- Insulin Lispro
-
Mainz, Rheinland-Pfalz, GermanyProfil Mainz GmbH & Co. KG
Jul 30, 2021
Diabetes, Type 1 Trial in Chula Vista (AT247, NovoLog, Fiasp)
Active, not recruiting
- Diabetes Mellitus, Type 1
- AT247
- +2 more
-
Chula Vista, CaliforniaProSciento, Inc
Aug 12, 2022
Accuracy Comparison of Two CGMs in Hospitalized Patients
Active, not recruiting
- Type 1 Diabetes
- Type 2 Diabetes
-
La Jolla, CaliforniaUC San Diego Medical Center
May 16, 2022
Faster Aspart on Insulin-pump Treated T1DM Patients
Completed
- Type 1 Diabetes
- Insulin Faster Aspart
- Insulin pump
-
Ciudad Real, SpainObispo Rafael Torija, St.
Jan 29, 2021
Diabetes, Type 1, Type 1 Diabetes, Type 1 Diabetes Trial in Melbourne (coil-reinforced soft polymer indwelling cannula)
Completed
- Diabetes Mellitus, Type 1
- +3 more
- coil-reinforced soft polymer indwelling cannula
-
Melbourne, AustraliaSt Vincent's Hospital (Melbourne) Ltd - Fitzroy
Jan 25, 2021
Type 1 Diabetes Trial in Santa Barbara (Sansum Closed-Loop Artificial Pancreas, Insulin infusion pump, Continuous Glucose
Completed
- Type 1 Diabetes Mellitus
- Sansum Closed-Loop Artificial Pancreas
- +4 more
-
Santa Barbara, CaliforniaSansum Diabetes Research Institute
Sep 7, 2021
Type 1 Diabetes Trial in Austin (Fiasp®, Novolog®, 670G hybrid closed loop continuous subcutaneous insulin infusion system)
Completed
- Type 1 Diabetes Mellitus
- Fiasp®
- +2 more
-
Austin, TexasTexas Diabetes & Endocrinology
Sep 9, 2020
Diabetes, Type 1, Pediatric ALL Trial in Gennevilliers (Monitoring of the patients)
Recruiting
- Diabetes Mellitus, Type 1
- Pediatric ALL
- Monitoring of the patients
-
Gennevilliers, Ile De France, FranceIsis Diabete Service
Dec 3, 2020
Type 1 Diabetes, Pregnancy, High Risk Trial in Worcester (Insulin)
Recruiting
- Type 1 Diabetes
- Pregnancy, High Risk
-
Worcester, MassachusettsUniversity of Massachusetts Memorial Medical Center
May 9, 2022
Type 1 Diabetes Trial in Spain (Insulin pump)
Completed
- Type 1 Diabetes
- Insulin pump
-
Badalona, Barcelona, Spain
- +24 more
Feb 8, 2022
Type 1 Diabetes Trial in Asheville (Faster Insulin Aspart (Fiasp®))
Recruiting
- Type 1 Diabetes Mellitus
- Faster Insulin Aspart (Fiasp®)
-
Asheville, North CarolinaMountain Diabetes and Endocrine Center
Nov 20, 2020
Type1 Diabetes Trial in Asheville (Aspart)
Completed
- Type1 Diabetes Mellitus
-
Asheville, North CarolinaMountain Diabetes and Endocrine Center
Feb 23, 2021
Type 1 Diabetes Trial in London (Insulin (circadian), Insulin (flat rate))
Completed
- Type 1 Diabetes
- Insulin (circadian)
- Insulin (flat rate)
-
London, United KingdomImperial College Clinical Research Facility
Mar 19, 2020